|
Post by phalange3 on Oct 13, 2016 0:06:03 GMT
Whereas, food allergies affect 8% of children and anaphylaxis is a life-threatening illness affecting 1.6% of the population1,2; and
Whereas, anaphylaxis commonly occurs outside the home after exposure to specific food or environmental allergens3; and
Whereas, emergency medical service response time can widely vary; and
Whereas, rapid autoinjectable epinephrine administration can greatly reduce morbidity and mortality of a child during an allergic reaction; and
Whereas, there is an incentive to autoinjectable epinephrine manufacturers to decrease the cost of autoinjectable epinephrine if there is an increase in the potential market; therefore be it
RESOLVED, that the Academy support legislation allowing autoinjectable epinephrine storage in public spaces such as schools, restaurants, and community centers without a prescription.
LEAD AUTHOR: Melissa Stone, MD
CO-AUTHOR: Ashley Landicho, MD, MBA
|
|
|
Post by Christian Pulcini on Oct 15, 2016 10:57:05 GMT
This is a really reasonable request and I fully support it. It may get caught up in the language, in which "the Academy advocate for autoinjectable epinephrine storage in public spaces..." may work better as it allows the Academy to tackle the issue outside the legislative realm. Excellent!
|
|
|
Post by jwschreiber on Oct 16, 2016 20:09:50 GMT
Agree with Christian about the language change, but I think this is very timely, especially with much of the epi pen controversy (if some families can't afford the pen will they not have it and thus the importance of having them available in public locations). Maybe one other factor of having increased training to people at these public places to administer it.
|
|
|
Post by GUEST on Oct 16, 2016 20:45:27 GMT
I think it would be important to include that said places have employees that are trained to use this.
|
|
|
Post by marcial on Oct 19, 2016 14:08:12 GMT
A very important battle is to significantly reduce the cost of such injectors, who will fit the bill for all these? The city, the small business owner? They expire very quickly (which should be evaluated in it self) and need proper storage in a non-abusable place if in public, it is a needle with medication that people could abuse
|
|
|
Post by GUEST on Oct 19, 2016 16:24:06 GMT
While it is important for children to have access to life-saving treatments, there are some problems with current movements to make epinephrine injectable pens more accessible. Mylan, the manufacturer of EpiPen, has been lobbying for laws that encourage stocking of EpiPens in public places www.nytimes.com/2016/09/16/business/epipen-maker-mylan-preventative-drug-campaign.html"Mylan was actively involved in pushing a 2013 federal law encouraging schools nationwide to stock EpiPens. And the company takes credit for legislation in at least 10 states that require the product in hotels, restaurants and other places, and additional school-related legislation in nearly every state. It is also helping push legislation pending in Congress that would require epinephrine auto-injectors on all commercial airline flights." This is something that Mylan is clearly going to have a substantial financial benefit with, yet it is not necessarily proven that it will save lives, and it will certainly be quite expensive.
|
|
zarah
New Member
Posts: 12
|
Post by zarah on Oct 20, 2016 18:04:43 GMT
I agree with the above commenter that we need to be careful of these types of mandates for expensive medications that are backed by pharmaceutical companies that are pushing their financial interests. There is a lot of evidence that Mylan aggressively pushed for legislation mandating that schools and other facilities stock EpiPens, and that once those laws were in place, they were able to push up the price of EpiPens because they had created a significantly inelastic demand curve for their products, since their primary clients did not have the option not to buy their product.
|
|
|
Post by Sarah on Oct 22, 2016 0:21:14 GMT
Yes
|
|
|
Post by joe on Oct 22, 2016 15:36:31 GMT
An additional issue 4. EpiPen: a nurse unfamiliar with the new design of the EpiPen accidentally injected her thumb by pushing on the wrong end (orange tip) of the pen, assuming that it was similar to the NovoLog FlexPen (insulin aspart), which has an orange button to inject the insulin. - in an app bulletin.
- I believe the AAP has advocated for a similar issue as I think the AAP and Allergy Association brought a resolution to the AMA a few years back.
|
|